156 related articles for article (PubMed ID: 16857330)
1. Core-shell type of nanoparticles composed of poly[(n-butyl cyanoacrylate)-co-(2-octyl cyanoacrylate)] copolymers for drug delivery application: synthesis, characterization and in vitro degradation.
Huang CY; Lee YD
Int J Pharm; 2006 Nov; 325(1-2):132-9. PubMed ID: 16857330
[TBL] [Abstract][Full Text] [Related]
2. Box-Behnken optimization design and enhanced oral bioavailability of thymopentin-loaded poly (butyl cyanoacrylate) nanoparticles.
Jin X; Huang A; Ping Q; Cao F; Su Z
Pharmazie; 2011 May; 66(5):339-47. PubMed ID: 21699067
[TBL] [Abstract][Full Text] [Related]
3. Cellular uptake and intracellular degradation of poly(alkyl cyanoacrylate) nanoparticles.
Sulheim E; Baghirov H; von Haartman E; Bøe A; Åslund AK; Mørch Y; Davies Cde L
J Nanobiotechnology; 2016 Jan; 14():1. PubMed ID: 26743777
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo evaluation of 10-hydroxycamptothecin-loaded poly (n-butyl cyanoacrylate) nanoparticles prepared by miniemulsion polymerization.
Jin X; Asghar S; Zhu X; Chen Z; Tian C; Yin L; Ping Q; Xiao Y
Colloids Surf B Biointerfaces; 2018 Feb; 162():25-34. PubMed ID: 29145001
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers.
He M; Zhao Z; Yin L; Tang C; Yin C
Int J Pharm; 2009 May; 373(1-2):165-73. PubMed ID: 19429302
[TBL] [Abstract][Full Text] [Related]
6. Poly (ethyl 2-cyanoacrylate) nanoparticles (PECA-NPs) as possible agents in tumor treatment.
Obinu A; Rassu G; Corona P; Maestri M; Riva F; Miele D; Giunchedi P; Gavini E
Colloids Surf B Biointerfaces; 2019 May; 177():520-528. PubMed ID: 30822627
[TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of polycyanoacrylates.
Barkan Y; Levinman M; Veprinsky-Zuzuliya I; Tsach T; Merqioul E; Blum G; Domb AJ; Basu A
Acta Biomater; 2017 Jan; 48():390-400. PubMed ID: 27826005
[TBL] [Abstract][Full Text] [Related]
8. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery.
Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J
Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197
[TBL] [Abstract][Full Text] [Related]
9. Enhanced oral bioavailability of 10-hydroxycamptothecin through the use of poly (n-butyl cyanoacrylate) nanospheres.
Jin X; Asghar S; Zhu X; Chen Z; Liu J; Li Y; Li H; Ping Q; Xiao Y
Drug Dev Ind Pharm; 2017 Oct; 43(10):1637-1647. PubMed ID: 28481657
[TBL] [Abstract][Full Text] [Related]
10. PEGylated polycyanoacrylate nanoparticles as salvicine carriers: synthesis, preparation, and in vitro characterization.
Li YP; Zhou ZH; Pei YY; Zhang XY; Gu ZH; Yuan WF
Acta Pharmacol Sin; 2001 Jul; 22(7):645-50. PubMed ID: 11749831
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-sensitive bis(2-(2'-benzothienyl)pyridinato-N,C(3'))iridium[poly(n-butyl cyanoacrylate]/chitosan nanoparticles and their phosphorescence tumor imaging in vitro and in vivo.
Zeng Y; Zhang S; Jia M; Liu Y; Shang J; Guo Y; Xu J; Wu D
Nanoscale; 2013 Dec; 5(24):12633-44. PubMed ID: 24177494
[TBL] [Abstract][Full Text] [Related]
12. Preparation and investigation of high solid content PTX-loaded nanoparticles dispersion via nanoprecipitation method.
Xiang Y; Xiao M; Han S; Xu S; Cao Y; Lv Z; Liu J; Liu J; Deng L; Dong A
J Biomater Sci Polym Ed; 2014; 25(11):1144-58. PubMed ID: 24894948
[TBL] [Abstract][Full Text] [Related]
13. Effects of phospholipid and polyethylene glycol monostearate (100) on the in vitro and in vivo physico-chemical characterization of poly(n-butyl cyanoacrylate) nanoparticles.
Jin X; Asghar S; Zhang M; Chen Z; Zhang J; Ping Q; Xiao Y
Colloids Surf B Biointerfaces; 2019 Jan; 173():320-326. PubMed ID: 30312943
[TBL] [Abstract][Full Text] [Related]
14. Development of curcuminoids loaded poly(butyl) cyanoacrylate nanoparticles: Physicochemical characterization and stability study.
Mulik R; Mahadik K; Paradkar A
Eur J Pharm Sci; 2009 Jun; 37(3-4):395-404. PubMed ID: 19491031
[TBL] [Abstract][Full Text] [Related]
15. Preparation of vincristine sulfate-loaded poly (butylcyanoacrylate) nanoparticles modified with pluronic F127 and evaluation of their lymphatic tissue targeting.
Tan R; Niu M; Zhao J; Liu Y; Feng N
J Drug Target; 2014 Jul; 22(6):509-17. PubMed ID: 24625287
[TBL] [Abstract][Full Text] [Related]
16. Selegiline-functionalized, PEGylated poly(alkyl cyanoacrylate) nanoparticles: Investigation of interaction with amyloid-β peptide and surface reorganization.
Le Droumaguet B; Souguir H; Brambilla D; Verpillot R; Nicolas J; Taverna M; Couvreur P; Andrieux K
Int J Pharm; 2011 Sep; 416(2):453-60. PubMed ID: 21251960
[TBL] [Abstract][Full Text] [Related]
17. Photo-oxidative action in MCF-7 cancer cells induced by hydrophobic cyanines loaded in biodegradable microemulsion-templated nanocapsules.
Wilk KA; Zielińska K; Pietkiewicz J; Skołucka N; Choromańska A; Rossowska J; Garbiec A; Saczko J
Int J Oncol; 2012 Jul; 41(1):105-16. PubMed ID: 22552322
[TBL] [Abstract][Full Text] [Related]
18. Poly(ester anhydride)/mPEG amphiphilic block co-polymer nanoparticles as delivery devices for paclitaxel.
Liang Y; Xiao L; Li Y; Zhai Y; Xie C; Deng L; Dong A
J Biomater Sci Polym Ed; 2011; 22(4-6):701-15. PubMed ID: 20566053
[TBL] [Abstract][Full Text] [Related]
19. Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies.
Joshi SA; Chavhan SS; Sawant KK
Eur J Pharm Biopharm; 2010 Oct; 76(2):189-99. PubMed ID: 20637869
[TBL] [Abstract][Full Text] [Related]
20. Artificial oxygen carriers based on perfluorodecalin-filled poly(n-butyl-cyanoacrylate) nanocapsules.
Stephan C; Schlawne C; Grass S; Waack IN; Ferenz KB; Bachmann M; Barnert S; Schubert R; Bastmeyer M; de Groot H; Mayer C
J Microencapsul; 2014; 31(3):284-92. PubMed ID: 24124886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
